Navigation

Intravenous fluid therapy

Intravenous fluid therapy in adults in hospital

Status: History
Publication date: December 2013
Wave: 25
Process: CG
Topic area:
  • Therapeutic procedures
 

NICE project team

Centre for clinical practice lead: Sharon Summers-Ma
Communications manager: Laura Gibson
Guidelines commissioning manager:

Claire Ruiz

Guidelines coordinator: Elaine Clydesdale
Patient involvement lead: Erin Whittingham
Implementation lead: Alexa Biesty
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 25 May 2011
Consultation on draft scope with stakeholders: 14 Jun 2011 - 5 July 2011
Consultation on draft guideline with stakeholders: 21 May 2013 - 3 July 2013
Publication date: December 2013
Top


 

Project history

Date Update
10 December 2013 CG174 Intravenous fluid therapy in adults in hospital published
4 October 2013

As a result of the Medicines Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) review of the suspension of the use of hydroxyethyl starch (HES) solutions, the release of the embargoed version and publication of the guideline will be delayed to ensure the guideline adequately reflects the latest MHRA position. The amendment to the guideline publication schedule are as follows:

  • Embargoed release of full guideline and comments table: 27 Nov 2013
  • Publication of guideline: 11 Dec 2013
21 May 2013 The draft guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
29 March 2012 The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. 
29 February In line with the draft methods for developing quality standards, the development of the quality standard will be the responsibility of a separate group.  This will include topics experts, some of whom will be drawn from the Guideline Development Group. The clinical guideline scope will form the basis from which the clinical guideline will be developed and the quality standard scope will inform the development of the quality standard, which will be developed following completion of the clinical guideline.
9 September 2011 The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.
4 January 2011 The remit was received from the Department of Health and the Welsh Assembly Government in February 2010 as part of the Institute's 25th wave work programme.
Top


 

Key documents

This page was last updated: 09 December 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.